Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inti Zlobec

Showing results (71-80 of 260) with videos related to

Pageof 26
Sort By:
Nature Communications|March 12, 2025
Editorial Expression of Concern: ATG5 is induced by DNA-damaging agents and promotes mitotic catastrophe independent of autophagyDipak Maskey, Shida Yousefi, Inès Schmid, et al.
Human Pathology|November 20, 2012
Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancerMilo Horcic, Viktor H Koelzer, Eva Karamitopoulou, et al.
Journal of Pathology Informatics|January 11, 2020
A Digital Pathology-Based Shotgun-Proteomics Approach to Biomarker Discovery in Colorectal CancerStefan Zahnd, Sophie Braga-Lagache, Natasha Buchs, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 6, 2007
Prognostic significance of mammalian sterile20-like kinase 1 in colorectal cancerParham Minoo, Inti Zlobec, Kristi Baker, et al.
Nature Clinical Practice. Gastroenterology & Hepatology|January 5, 2007
Napoleon Bonaparte's gastric cancer: a clinicopathologic approach to staging, pathogenesis, and etiologyAlessandro Lugli, Inti Zlobec, Gad Singer, et al.
BMC Gastroenterology|June 17, 2010
Role of tumor size in the pre-operative management of rectal cancer patientsInti Zlobec, Parham Minoo, Eva Karamitopoulou, et al.
Gut|February 15, 2023
Spatially restricted tumour-associated and host-associated immune drivers correlate with the recurrence sites of pancreatic cancerEva Karamitopoulou, Anna Silvia Wenning, Animesh Acharjee, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 3, 2006
Scoring of p53, VEGF, Bcl-2 and APAF-1 immunohistochemistry and interobserver reliability in colorectal cancerInti Zlobec, Russell Steele, René P Michel, et al.
Cancer|December 14, 2007
Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancerInti Zlobec, Parham Minoo, Daniel Baumhoer, et al.
Human Pathology|July 27, 2006
Role of the mitogen-activated protein kinase and phosphoinositide 3-kinase/AKT pathways downstream molecules, phosphorylated extracellular signal-regulated kinase, and phosphorylated AKT in colorectal cancer-a tissue microarray-based approachAlessandro Lugli, Inti Zlobec, Parham Minoo, et al.
Pageof 26

Showing results (71-80 of 260) with videos related to

Sort By:
Pageof 26
Nature Communications|March 12, 2025
Editorial Expression of Concern: ATG5 is induced by DNA-damaging agents and promotes mitotic catastrophe independent of autophagyDipak Maskey, Shida Yousefi, Inès Schmid, et al.
Human Pathology|November 20, 2012
Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancerMilo Horcic, Viktor H Koelzer, Eva Karamitopoulou, et al.
Journal of Pathology Informatics|January 11, 2020
A Digital Pathology-Based Shotgun-Proteomics Approach to Biomarker Discovery in Colorectal CancerStefan Zahnd, Sophie Braga-Lagache, Natasha Buchs, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 6, 2007
Prognostic significance of mammalian sterile20-like kinase 1 in colorectal cancerParham Minoo, Inti Zlobec, Kristi Baker, et al.
Nature Clinical Practice. Gastroenterology & Hepatology|January 5, 2007
Napoleon Bonaparte's gastric cancer: a clinicopathologic approach to staging, pathogenesis, and etiologyAlessandro Lugli, Inti Zlobec, Gad Singer, et al.
BMC Gastroenterology|June 17, 2010
Role of tumor size in the pre-operative management of rectal cancer patientsInti Zlobec, Parham Minoo, Eva Karamitopoulou, et al.
Gut|February 15, 2023
Spatially restricted tumour-associated and host-associated immune drivers correlate with the recurrence sites of pancreatic cancerEva Karamitopoulou, Anna Silvia Wenning, Animesh Acharjee, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 3, 2006
Scoring of p53, VEGF, Bcl-2 and APAF-1 immunohistochemistry and interobserver reliability in colorectal cancerInti Zlobec, Russell Steele, René P Michel, et al.
Cancer|December 14, 2007
Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancerInti Zlobec, Parham Minoo, Daniel Baumhoer, et al.
Human Pathology|July 27, 2006
Role of the mitogen-activated protein kinase and phosphoinositide 3-kinase/AKT pathways downstream molecules, phosphorylated extracellular signal-regulated kinase, and phosphorylated AKT in colorectal cancer-a tissue microarray-based approachAlessandro Lugli, Inti Zlobec, Parham Minoo, et al.
Pageof 26